MCHENRY, Ill. and LAKE FOREST, Calif., Nov. 1, 2018
MCHENRY, Ill. and LAKE FOREST, Calif., Nov. 1, 2018 /PRNewswire/ -- Medela LLC announced today that Apria Healthcare, one of the nation's largest providers of home healthcare and equipment services, will begin distributing Medela's negative pressure wound therapy (NPWT) product line on a national basis.
Under the terms of the agreement, Apria will expand its wound care portfolio to include the full line of Medela's negative pressure wound therapy products, including the Invia® NPWT System with FitPad. Apria will offer the Medela products through its more than 300 local branch offices and its nearly 1,900 commercial payers and preferred provider arrangements with integrated health systems across the country.
"I am excited about bringing Apria and Medela together," said Kevin Ackermann, vice president of healthcare for Medela USA. "By offering a united front, these two companies can help remove the complexities that occur in coordinating patient care from hospital to home, providing wider access to Medela's leading technology nationwide."
Medela's proprietary wound care system, featuring intelligent pressure control and dynamic exudate removal, provides users with the confidence that the prescribed therapy is being delivered at the wound site. This same system can be used in both the acute care and home care settings.
"We believe that our patients, prescribers and healthcare providers will immediately see the benefit of using the Invia NPWT system with FitPad in both the acute care and home care space, and of having Apria's dedicated sales team assist in safely getting these patients back home and coordinating their ongoing care," said Jeff C. Johnson, vice president business development for Apria.
About Medela LLC
Medela's swiss roots trace back to its founding in 1961 by Olle Larsson. Today his son, Michael Larsson, leads 18 subsidiaries, distributing in over 100 countries, and employs over 1800 people worldwide. The Medela brand name is most commonly recognized for its market leading breast pump portfolio. But at its core Medela is an innovator of medical vacuum technologies. These innovations extend into Negative Pressure Wound Therapy, CardioThoracic Drainage, Surgical Suction, Airway Suction, and Enteral Feeding. For more information about Medela products, e-mail inquiries to email@example.com, call 877-735-1626 or visit www.medela-healthcare.us.
About Apria Healthcare Group Inc.
Apria is a privately held company owned by a group of investment limited partnerships managed by affiliates of Blackstone (NYSE:BX). Through its Apria Healthcare LLC operating unit, Apria provides home respiratory therapy, negative pressure wound therapy, home enteral nutrition therapy and support, and home medical equipment through more than 300 locations throughout the continental United States and Hawaii and serves more than 1.8 million patients each year. With over $1 billion in annual revenues, Apria is one of the nation's largest and leading home healthcare companies. Apria was the first company of its type to obtain voluntary accreditation from The Joint Commission and has been continuously accredited for more than 25 years. For more information visit www.apria.com.
Medela wordmark and logo and Invia are registered in the U.S Patent and Trademark Office. © 2018 Medela
View original content to download multimedia:http://www.prnewswire.com/news-releases/medela-and-apria-announce-nationwide-distribution-agreement-for-negative-pressure-wound-therapy-300741258.html